Newsbenzinga
Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion
· Published
Article summary
Regeneron and Sanofi expand their 20-year antibody collaboration with a $1 billion upfront payment and new clinical trials.
An excerpt from the original article.
Comments —
Loading comments…